Viewing Study NCT02509351


Ignite Creation Date: 2025-12-24 @ 11:47 PM
Ignite Modification Date: 2026-02-20 @ 12:41 PM
Study NCT ID: NCT02509351
Status: COMPLETED
Last Update Posted: 2016-11-10
First Post: 2015-07-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Could Pre-operative Rectal Misoprostol Reduce Intra-operative Blood Loss During Ceserean Section?
Sponsor: Ain Shams University
Organization:

Study Overview

Official Title: Randomized, Placebo-controlled Double Blind Study of Preoperative Misorostol for Reduction of Intraoperative Bleeding in Women Delivered by Ceserean Section
Status: COMPLETED
Status Verified Date: 2016-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: * Misoprostol reduces the uterine bleeding after cesarean delivery without harmful effects on either mother or baby.
* The aim of the this study is to address if there is any benefits 'regarding the intra-operative blood loss' from preoperative rectal administration of 400 mic of Misoprostol in addition to the routinely administrated 10 units of oxytocin
Detailed Description: Research question:

In women undergoing elective ceserean section, is preoperative 400 mic Misoprostol reduce intra-operative blood loss?

Research hypothesis:

pre-operative Misoprostol doesn't reduce intraoperative blood loss in women undergoing ceserean section

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: